• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Sex Differences in Energy Demand in Alzheimer’s Model

Bioengineer by Bioengineer
October 19, 2025
in Biology
Reading Time: 4 mins read
0
blank
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A groundbreaking study published in “Biology of Sex Differences” highlights the intricate dynamics of energy demand variations between male and female subjects during the preplaque stage of Alzheimer’s disease, utilizing a transgenic mouse model that mirrors human Alzheimer’s pathology. This pivotal research led by a team of scientists, including Ren Sun, Lisa K. Zimbalski, and Sebastian Schreyer, sheds light on the fundamental biological mechanisms that may contribute to the observed sex differences in the prevalence and pathology of Alzheimer’s disease. As researchers continue to unravel the complex relationship between sex and neurodegenerative diseases, the findings present significant implications for future therapeutic interventions tailored according to sex-specific needs.

The preplaque stage, marked by the early accumulation of amyloid-beta peptide aggregates in the brain, is a critical window for understanding the progression of Alzheimer’s disease. In their study, the researchers deployed a transgenic mouse model engineered to exhibit characteristics akin to typical Alzheimer’s pathology. This model is particularly valuable for probing the early stages of the disease, thus providing a framework within which to assess and analyze energy metabolism rates in a controlled environment.

Focusing on energy demand, the study reveals that physiological variances exist between sexes even before full-blown plaque deposition occurs. This phenomenon underscores the necessity of incorporating sex as a biological variable into the research of Alzheimer’s disease, which has historically been predominantly male-centered. The researchers meticulously measured energy expenditure in male and female mice, observing marked differences that could explain the distinctive clinical trajectories observed in Alzheimer’s patients.

The implications of these findings extend beyond basic science into the realm of clinical applications. Given that women are disproportionately affected by Alzheimer’s disease, understanding these sex-specific energy demands may pave the way for interventions that could bolster energy metabolism and potentially delay cognitive decline. The interplay between energy demand and cognitive function is an evolving area of research, and the insights garnered from this study offer a tantalizing glimpse into future strategies for combating Alzheimer’s disease.

Moreover, the researchers analyzed how alterations in energy metabolism relate to behavioral changes in the mice, providing a comprehensive picture of the consequences of sex-specific energy demand. This behavioral analysis, coupled with metabolic measurements, provides a holistic view of the impact of energy requirements on cognitive health. Such an integrated approach is vital for mapping the multifaceted trajectory of Alzheimer’s disease and for elucidating the potential areas of intervention.

From a molecular perspective, the team delved into the underlying pathways responsible for these energy demand changes. By correlating neurobiological data with metabolic rates, the study highlighted specific metabolic pathways that were activated differently in males and females. This information is invaluable for researchers who aim to develop targeted therapies aimed at modifying these specific pathways to optimize energy production and consumption in the brain.

As we advance our understanding of neurodegenerative disorders, the study urges a reevaluation of how sex-specific differences can influence not only disease susceptibility but also treatment efficacy. Investigators are called to consider these variations in energy metabolism as they design clinical trials and therapeutic interventions. Future studies could explore potential treatments aimed explicitly at mitigating or enhancing sex-specific metabolic pathways, thereby tailoring therapeutic approaches based on an individual’s biological sex.

Additionally, considering environmental factors alongside genetic predisposition may also be crucial in addressing Alzheimer’s disease progression. This research opens avenues for multidisciplinary approaches combining lifestyle interventions with medical treatment to address the nuances of energy metabolism. Such a comprehensive strategy could involve dietary modifications, physical activity, and other lifestyle choices that can influence energy metabolism in a manner beneficial to cognitive health.

Ultimately, as the landscape of Alzheimer’s research continues to shift towards a more inclusive perspective that embraces sex differences, the contributions of studies like this one become increasingly vital. By drawing attention to the specific energy demands of male and female models, the authors encourage a broader discussion about how we understand neurodegeneration and its diverse physiological impacts.

In conclusion, the findings of Sun et al. represent a significant step forward in the quest to unravel the complexities of sex differences in Alzheimer’s disease. By meticulously documenting the variances in energy demands during the preplaque stage, this research not only advances our theoretical understanding but also carries profound implications for future clinical practices. As the science of Alzheimer’s disease evolves, integrating such insights will be paramount in the ongoing fight against this devastating condition. Addressing the gaps in sex-specific research may lead to a paradigm shift in treatment strategies, thereby enhancing the quality of life for those affected by Alzheimer’s disease.

The surge of interest in gender-specific research in neurodegenerative diseases is indicative of a broader trend that prioritizes personalized medicine. Moving forward, it is imperative that research institutions collaborate across disciplines to cultivate a more nuanced understanding of the intersection between gender, metabolism, and neurological health. By aligning research with the realities of clinical experience, we hold the potential to foster breakthroughs that can transform the landscape of Alzheimer’s disease treatment and prevention.

In essence, as we commemorate the efforts of researchers pushing the boundaries of our understanding, we also look forward to a future where interventions are as unique as the individuals they aim to help.

Subject of Research: Alzheimer’s disease, energy demand, sex differences in neurodegeneration

Article Title: Sex-specific changes in energy demand during the preplaque stage in a transgenic Alzheimer’s mouse model.

Article References:

Sun, R., Zimbalski, LK., Schreyer, S. et al. Sex-specific changes in energy demand during the preplaque stage in a transgenic Alzheimer’s mouse model. Biol Sex Differ 16, 54 (2025). https://doi.org/10.1186/s13293-025-00737-0

Image Credits: AI Generated

DOI: 10.1186/s13293-025-00737-0

Keywords: Alzheimer’s disease, sex differences, energy metabolism, preplaque stage, transgenic mouse model, neurodegeneration, personalized medicine.

Tags: Alzheimer’s disease sex differencesamyloid-beta peptide dynamicsbiological mechanisms Alzheimer’s pathologyearly stages of Alzheimer’s diseaseenergy demand in neurodegenerationgender differences in disease prevalenceimplications for Alzheimer’s treatmentNeurodegenerative disease researchphysiological variances in energy metabolismpreplaque stage Alzheimer’ssex-specific therapeutic interventionstransgenic mouse model Alzheimer’s

Share13Tweet8Share2ShareShareShare2

Related Posts

Scn1b/Gsdmd knockdown promotes M2-like macrophages, modulating inflammation and fibrosis in rat ARDS

Scn1b/Gsdmd knockdown promotes M2-like macrophages, modulating inflammation and fibrosis in rat ARDS

August 26, 2026
Plant Enzymes Enable Efficient Production of N-(Hydroxycinnamoyl)tyramines with In Situ Precipitation

Plant Enzymes Enable Efficient Production of N-(Hydroxycinnamoyl)tyramines with In Situ Precipitation

August 26, 2026

FOXP3, Key Regulatory T Cell Activator, Found Across Amphibians

August 26, 2026

MSR Gene Discovery in Four Wheat Species Reveals TaMSRB5 Enhances Copper Tolerance

August 26, 2026

POPULAR NEWS

  • Pathogenic MECP2 Variants Reveal Broader Neurological Spectrum Beyond Rett Syndrome

    29 shares
    Share 12 Tweet 7
  • Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification

    29 shares
    Share 12 Tweet 7
  • Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer

    29 shares
    Share 12 Tweet 7
  • Air-Treated Bamboo Yields Balanced-Pore Activated Carbon for Toluene Removal

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pathogenic MECP2 Variants Reveal Broader Neurological Spectrum Beyond Rett Syndrome

Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification

Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.